Protagonist Therapeutics, Inc. (PTGX)

104.75 -1.14 (-1.08%) USD  |  NASDAQ  |  Apr 22, 12:19
More

Protagonist Therapeutics Hold Recommendations

Hold Recommendations Chart

View Hold Recommendations for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Hold Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Hold Recommendations Range, Past 5 Years

View Hold Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Hold Recommendations Benchmarks

View Hold Recommendations Benchmarks
Start Trial
Johnson & Johnson Upgrade
AbbVie, Inc. Upgrade
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade